• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Progen Pharmaceuticals Ltd

+ Add to Watchlist

PGLA:US

0.3500 USD 0.9000 72.00%

As of 20:10:00 ET on 07/28/2014.

Snapshot for Progen Pharmaceuticals Ltd (PGLA)

Open: 0.3000 Day's Range: 0.2360 - 0.3500 Volume: 81,723
Previous Close: 1.2500 52wk Range: 0.1351 - 1.8600 1-Yr Rtn: +204.35%

Stock Chart for PGLA

No chart data available.
  • PGLA:US 0.3500
  • 1D
  • 1M
  • 1Y
1.2500
Interactive PGLA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PGLA

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. SPX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2014) -
Est. PEG Ratio -
Market Cap (M USD) 19.35
Shares Outstanding (M) 55.29
30 Day Average Volume 7,369
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/27/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PGLA

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for PGLA

Progen Pharmaceuticals Limited is involved in the discovery, research and development of potential biopharmaceutical therapeutics for the treatment of human diseases. The Company also provides contract services related to the process development, manufacture and quality assurance of biological products.

Indrajit Solomon Arulampalam "Jitto"ChairmanHeng Hsin TangActing Managing Director
Lee HorobinGen Mgr:FinanceFleur LankesheerDir:Bus Development & Legal
More Company Profile & Key Executives for PGLA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil